Ownership history in XTX Topco Ltd · 6 quarters on record
This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in PRELUDE THERAPEUTICS INC (PRLD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 50,159 | +34,581 | +222.0% | 0.00% | $145K | $2.90 |
| 2025 Q3 | REDUCED | 15,578 | -26,995 | -63.4% | 0.00% | $22K | $1.44 |
| 2025 Q2 | ADDED | 42,573 | +17,873 | +72.4% | 0.00% | $34K | $0.81 |
| 2025 Q1 | REDUCED | 24,700 | -13,639 | -35.6% | 0.00% | $19K | $0.77 |
| 2024 Q4 | REDUCED | 38,339 | -9,900 | -20.5% | 0.00% | $49K | $1.27 |
| 2024 Q3 | INITIATED | 48,239 | — | — | 0.01% | $100K | $2.07 |
As of 2025 Q4 — sorted by position size